Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
76,991,404
-
Total 13F shares
-
7,942,384
-
Share change
-
+920,529
-
Total reported value
-
$23,036,168
-
Put/Call ratio
-
873%
-
Price per share
-
$2.90
-
Number of holders
-
44
-
Value change
-
+$2,760,761
-
Number of buys
-
20
-
Number of sells
-
13
Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q4 2019
As of 31 Dec 2019,
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,942,384 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, VANGUARD GROUP INC, BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, FIRST MANHATTAN CO, Tekla Capital Management LLC, GROUP ONE TRADING, L.P., and OXFORD ASSET MANAGEMENT LLP.
This page lists
44
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.